![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.675 | 4.36 | 4.99 | - | 60,335 | 08:00:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
30/3/2020 14:59 | it looked a climbing chart from the beginning today. Excellent! | ![]() hazl | |
30/3/2020 14:58 | Most gracious of you Dave, I shall do so when I’m ready. I should like to reciprocate a similar offer. | ![]() 801710245 | |
30/3/2020 14:58 | 17 MAR.....14 day dosing trial started. 26 MAR.....Placing for £14m including £4m to manufacture SNG001. 31 MAR.....14 day dosing trial ends. CONCLUSION: After already dosing patients for 8-9 days of 14 day dosing trial they raised £4m to manufacture SNG001. They would not do this if it failed. Conclusion: SUCCESSFUL TRIAL. Initial observations/results by end of week, either officially or a leak imho. They will not be able to keep this quiet. Just not possible. Lots of patients/familes,nur | ![]() lithological heterogeneities | |
30/3/2020 14:52 | Pharma ffs | ![]() bobaxe1 | |
30/3/2020 14:52 | Like most Sharma's costsand dilution happen until the market realizes a development is about to hit the world it then you can expect a mega deal/ bagger!!! | ![]() bobaxe1 | |
30/3/2020 14:50 | That would be great | ![]() dave444 | |
30/3/2020 14:49 | ToffeemanFantastic .Very well played. That's the correct way to do it.Congratulations ! | ![]() lithological heterogeneities | |
30/3/2020 14:46 | I sold 25% of my holding at 22.715. This paid for my original purchase at 5.9 I have let 75% run | ![]() toffeeman | |
30/3/2020 14:43 | I am expecting more than £1 this week.Strong feeling a global deal will be announced to distribute SNG001 very soon. | ![]() lithological heterogeneities | |
30/3/2020 14:32 | I am hoping for a pound this week | ![]() dave444 | |
30/3/2020 14:31 | Remember we already hit high 60s last weekThat was just testing the water. | tidy 2 | |
30/3/2020 14:30 | 8017 - you are welcome to push off to NCYT | ![]() dave444 | |
30/3/2020 14:28 | I am not sur that is worth working out. If it works, I don't think there is any doubt they will make an enormous profit from this program. Toffee's ten bagger will turn into a hundred bagger.... | ![]() nobbygnome | |
30/3/2020 14:25 | Nobby, I wonder how long (or how many tests would need to be sold) for the cost of R&D to match the received revenue? | ![]() 801710245 | |
30/3/2020 14:25 | Did you not sell in the 20s toffeeman? | ![]() talk2dubya | |
30/3/2020 14:24 | When I can see sells at 60 I will have my first (and probably only) 10 bagger. | ![]() toffeeman | |
30/3/2020 14:22 | At least £1000 was the quote from Richard Marsden the CEO.... | ![]() nobbygnome | |
30/3/2020 14:22 | Good luck getting 75 percent of turkeys vote for Christmas on the conditional placing at this rate. | ![]() talk2dubya | |
30/3/2020 14:14 | Thanks tidy. | ![]() 801710245 | |
30/3/2020 14:06 | Not sure where the $1,000 cost of treatment above has come from however, Finncap have assumed a treatment cost of $5,000 for a 10 day course of SNG001 | ![]() lithological heterogeneities | |
30/3/2020 14:03 | Reversed so cancelled out. | tidy 2 | |
30/3/2020 14:01 | Yes I think so ! | ![]() tialouise | |
30/3/2020 14:00 | 275,000. Buy, sell, delayed? | ![]() 801710245 | |
30/3/2020 13:50 | Buying is relentless. Going to be an interesting week, I think/hope we will get an RNS on the WHO trials. | ![]() talk2dubya |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions